Cargando…

Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report

Advanced endometrial cancer is associated with poor outcomes and few treatment options exist. Recently, the US Federal Drug Administration approved pembrolizumab for the treatment of endometrial cancers that are deficient in mismatch repair and have high microsatellite instability (MSI). Lynch syndr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batman, Samantha, Rauh-Hain, J. Alejandro, Grinsfelder, Michaela Onstad, Harrison, Ross, Avila, Monica, Cun, Han, How, Jeffrey Andrew, Tandon, Nidhi, Wang, Xiaohong, Hinchcliff, Emily, Jazaeri, Amir Anthony, Schmeler, Kathleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134052/ https://www.ncbi.nlm.nih.gov/pubmed/37123608 http://dx.doi.org/10.1159/000530154

Ejemplares similares

Paget’s Disease of the Bone and Lynch Syndrome: An Exceptional Finding
por: Gheorghe, Ana-Maria, et al.
Publicado: (2023)

Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report
por: Adabifirouzjaei, Fatemeh, et al.
Publicado: (2021)

Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
por: Hearon, Bernard F., et al.
Publicado: (2020)

Lynch Syndrome in Thai Endometrial Cancer Patients
por: Manchana, Tarinee, et al.
Publicado: (2021)

Fertility-Sparing and Less Radical Surgery for Cervical Cancer
por: Batman, Samantha H., et al.
Publicado: (2022)

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer
por: Salman, Pamela, et al.
Publicado: (2018)

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma
por: Cuncannon, Moire, et al.
Publicado: (2019)

Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
por: Lee, Amy H., et al.
Publicado: (2022)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Retroperitoneal Hematoma as an Atypical Presentation of Choriocarcinoma: A Case Report
por: Pham, Truce, et al.
Publicado: (2023)

Prolonged Treatment Response to Pembrolizumab in a Patient with Pretreated Metastatic Colon Cancer and Lynch Syndrome
por: Keating, Matthew, et al.
Publicado: (2019)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
por: Hancock, Bradley A., et al.
Publicado: (2019)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
por: Kawagoe, Tetsuro, et al.
Publicado: (2020)

Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond
por: Alsina, Maria, et al.
Publicado: (2022)

Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome
por: Woolderink, Jorien M., et al.
Publicado: (2020)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma
por: Patil, Neha R., et al.
Publicado: (2020)

Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
por: Corazzelli, Gaetano, et al.
Publicado: (2011)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
por: Geva, Ravit, et al.
Publicado: (2013)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma
por: Chan, Joseph, et al.
Publicado: (2020)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium
por: Wang, Yiying, et al.
Publicado: (2013)

Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers
por: Egoavil, Cecilia, et al.
Publicado: (2013)

The gate-keeping role of surgeons with regard to endometrial cancers in Lynch syndrome
por: Kim, Min Kyu
Publicado: (2017)

The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma
por: Wang, Aifen, et al.
Publicado: (2018)

Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial Cancer
por: Ryan, Neil A. J., et al.
Publicado: (2020)

Associations of Height With the Risks of Colorectal and Endometrial Cancer in Persons With Lynch Syndrome
por: Brouwer, Jesca G M, et al.
Publicado: (2020)

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
por: Makker, Vicky, et al.
Publicado: (2020)

Pembrolizumab in endometrial cancer: Where we stand now
por: Aravantinou-Fatorou, Aikaterini, et al.
Publicado: (2021)

Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
por: El-ghazzi, Nathan, et al.
Publicado: (2023)

Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
por: How, Jeffrey A., et al.
Publicado: (2021)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

Testing Women With Endometrial Cancer for Lynch Syndrome: Should We Test All?
por: Ma, Jun, et al.
Publicado: (2013)

The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol
por: Ryan, Neil A. J., et al.
Publicado: (2018)

Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer
por: Snowsill, Tristan M., et al.
Publicado: (2020)

Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer
por: Ren, Caixia, et al.
Publicado: (2020)

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
por: Post, Cathalijne C B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0ev6aa73ti2bo779u48abet9ki